249 related articles for article (PubMed ID: 9683072)
1. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
7. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.
Preziosi R; Sarli G; Benazzi C; Marcato PS
J Comp Pathol; 1995 Nov; 113(4):301-13. PubMed ID: 8746954
[TBL] [Abstract][Full Text] [Related]
8. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance.
Nieto A; Peña L; Pérez-Alenza MD; Sánchez MA; Flores JM; Castaño M
Vet Pathol; 2000 May; 37(3):239-47. PubMed ID: 10810988
[TBL] [Abstract][Full Text] [Related]
9. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
10. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
[TBL] [Abstract][Full Text] [Related]
13. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
14. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR
APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
Geraldes M; Gärtner F; Schmitt F
Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of bcl-2, ER-alpha, caspase -3, -8, -9, PCNA and Ki-67 expressions in canine mammary carcinomas.
Aydogan A; Ozmen O; Haligur M; Sipahi C; Ileri D; Haligur A
Biotech Histochem; 2018; 93(4):286-292. PubMed ID: 29565181
[TBL] [Abstract][Full Text] [Related]
18. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
[TBL] [Abstract][Full Text] [Related]
19. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]